These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2445179)

  • 1. Critical oxygen delivery levels during shock following normoxic and hyperoxic haemodilution with fluorocarbons or dextran.
    Faithfull NS; Cain SM
    Adv Exp Med Biol; 1987; 215():79-87. PubMed ID: 2445179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of acute cardiovascular effects and oxygen-supply following haemodilution with dextran, stroma-free haemoglobin solution and fluorocarbon suspension.
    Biro GP
    Cardiovasc Res; 1982 Apr; 16(4):194-204. PubMed ID: 6179621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemodilution with dextran, stroma-free hemoglobin solution and fluosol-DA on experimental myocardial ischemia in the dog.
    Biro GP
    Bibl Haematol; 1981; (47):54-69. PubMed ID: 6175307
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluorocarbon and dextran hemodilution in myocardial ischemia.
    Biro GP
    Can J Surg; 1983 Mar; 26(2):163-8. PubMed ID: 6186351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of haemodilution with fluorocarbons or dextran on oxygen tensions in the acutely ischaemic myocardium.
    Faithfull NS; Erdmann W; Fennema M; Kok A
    Br J Anaesth; 1986 Sep; 58(9):1031-40. PubMed ID: 2428389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological supply dependence of systemic and intestinal O2 uptake during endotoxemia.
    Nelson DP; Samsel RW; Wood LD; Schumacker PT
    J Appl Physiol (1985); 1988 Jun; 64(6):2410-9. PubMed ID: 3136126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and intestinal limits of O2 extraction in the dog.
    Nelson DP; King CE; Dodd SL; Schumacker PT; Cain SM
    J Appl Physiol (1985); 1987 Jul; 63(1):387-94. PubMed ID: 3114223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fluorocarbons with and without oxygen supplementation on cardiac hemodynamics and energetics.
    Rude RE; Bush LR; Tilton GD
    Am J Cardiol; 1984 Oct; 54(7):880-3. PubMed ID: 6207721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of various colloidal solutions during major abdominal surgery.
    Nishimura N; Hiranuma N; Sugi T
    Crit Care Med; 1983 Dec; 11(12):940-2. PubMed ID: 6196154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against myocardial ischaemia by prior haemodilution with fluorocarbon emulsions.
    Faithfull NS; Fennema M; Erdmann W
    Br J Anaesth; 1988 Jun; 60(7):773-8. PubMed ID: 3395536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial Canadian experience with artificial blood (Fluosol-DA-20%) in severely anemic patients.
    Stefaniszyn HJ; Wynands JE; Salerno TA
    J Cardiovasc Surg (Torino); 1985; 26(4):337-42. PubMed ID: 4019576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Fluosol-DA and hetastarch on local cerebral blood flow, cortical O2 availability and computerized EEG data during cerebral ischaemia.
    Tranmer BI; Iacobacci R; Feiler S
    Neurol Res; 1990 Mar; 12(1):17-22. PubMed ID: 1692110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hyperthermia and hypothermia on oxygen extraction by tissues during hypovolemia.
    Schumacker PT; Rowland J; Saltz S; Nelson DP; Wood LD
    J Appl Physiol (1985); 1987 Sep; 63(3):1246-52. PubMed ID: 3654470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The place for using erythrocyte substitutes in hemodilution: fluosol-DA and polymerized pyridoxylated hemoglobin].
    Vigneron C; Labrude P; Dellacherie E
    Ann Fr Anesth Reanim; 1986; 5(3):260-8. PubMed ID: 3535579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Fluosol-DA on oxygen availability in focal cerebral ischemia.
    Sutherland GR; Farrar JK; Peerless SJ
    Stroke; 1984; 15(5):829-35. PubMed ID: 6433517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cerebral ischemia with Dextran-40 or Fluosol DA 20%.
    Kline RA; Negendank W; McCoy LE
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):979-83. PubMed ID: 1382645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies with Fluosol, Dextran, their mixture, or autologous blood in experimental hypovolemic shock.
    Madjidi A; Beisbarth H; Frey R
    Prog Clin Biol Res; 1983; 122():391-7. PubMed ID: 6192451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorocarbon emulsions: methodology to assess efficacy.
    Rosen AL; Sehgal LR; Gould SA; Sehgal H; Dalton L; Rice CL; Moss GS
    Crit Care Med; 1982 Mar; 10(3):149-54. PubMed ID: 7060386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced oxygen delivery by perflubron emulsion during acute hemodilution.
    Keipert PE; Faithfull NS; Bradley JD; Hazard DY; Hogan J; Levisetti MS; Peters RM
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1161-7. PubMed ID: 7849918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis and treatment of myocardial ischaemia by haemodilution with fluorocarbon emulsions.
    Faithful NS; Fennema M; Erdmann W
    Adv Exp Med Biol; 1987; 215():89-95. PubMed ID: 3673746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.